Journal of General Virology, Vol 79, 353-361, Copyright © 1998 by Society for General Microbiology

ARTICLES

Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes

Z Mikloska and AL Cunningham
Centre for Virus Research, Westmead Institutes for Health Research, Westmead Hospital, Australia.

T lymphocytes are the main mediators of the protective immune response in recurrent herpes simplex. Early in the development of recurrent lesions, macrophages and CD4 T lymphocytes predominate in the mononuclear infiltrate surrounding infected epidermal cells. Human epidermal keratinocytes allow herpes simplex virus type 1 (HSV-1) replication and human leukocyte antigen (HLA)-DR is strongly expressed in vivo. In vitro, their pretreatment with IFN-gamma induced HLA-DR expression and partially reversed major histocompatibility complex class I down-regulation by the virus. Mononuclear cell cytotoxicity for these cells was mediated predominantly by CD4 and also by CD8 T cells. Late HSV-1 proteins were the major targets for CD4 CTL, while CD8 CTL predominantly targeted early HSV-1 proteins. Here it is shown that both mononuclear and CD4 CTL consistently recognized the major HSV-1 glycoproteins, gB, gC, gD and gH, using IFN-gamma-pretreated keratinocytes infected with vaccinia virus-HSV glycoprotein recombinants (VvgB, VvgC, VvgD or VvgH). CD4 cytotoxicity was highest for VvgD-infected keratinocytes, followed by VvgB or VvgC and then VvgH in seven patients. CD4 CTL from two of 13 patients also recognized an epitope in the HSV tegument protein VP16, demonstrated by comparing cytotoxicity for the partial deletion mutants RP3 or RP4 and the parental RP1 HSV strain. In summary, the major HSV glycoproteins gB, gC and gD were consistently the major targets for CD4 CTL in VvgB-, VvgC-, VvgD- and VvgH-infected, IFN-gamma-pretreated human epidermal keratinocytes in vitro.

This article has been cited by other articles:

				X. Zhang, F. A. Castelli, X. Zhu, M. Wu, B. Maillere, and L. BenMohamed Gender-Dependent HLA-DR-Restricted Epitopes Identified from Herpes Simplex Virus Type 1 Glycoprotein D Clin. Vaccine Immunol., September 1, 2008; 15(9): 1436 - 1449. [Abstract] [Full Text] [PDF]

				A. A. Chentoufi, X. Zhang, K. Lamberth, G. Dasgupta, I. Bettahi, A. Nguyen, M. Wu, X. Zhu, A. Mohebbi, S. Buus, et al. HLA-A*0201-Restricted CD8+ Cytotoxic T Lymphocyte Epitopes Identified from Herpes Simplex Virus Glycoprotein D J. Immunol., January 1, 2008; 180(1): 426 - 437. [Abstract] [Full Text] [PDF]

				K. R. Mott, Y. Osorio, E. Maguen, A. B. Nesburn, A. E. Wittek, S. Cai, S. Chattopadhyay, and H. Ghiasi Role of Anti-Glycoproteins D (Anti-gD) and K (Anti-gK) IgGs in Pathology of Herpes Stromal Keratitis in Humans Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2185 - 2193. [Abstract] [Full Text] [PDF]

				H. Lauterbach, C. Ried, A. L. Epstein, P. Marconi, and T. Brocker Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity J. Gen. Virol., September 1, 2005; 86(9): 2401 - 2410. [Abstract] [Full Text] [PDF]

				Y. Huang, L. A. Babiuk, and S. van Drunen Littel-van den Hurk Immunization with a bovine herpesvirus 1 glycoprotein B DNA vaccine induces cytotoxic T-lymphocyte responses in mice and cattle J. Gen. Virol., April 1, 2005; 86(4): 887 - 898. [Abstract] [Full Text] [PDF]

				L. Aurelian Herpes Simplex Virus Type 2 Vaccines: New Ground for Optimism? Clin. Vaccine Immunol., May 1, 2004; 11(3): 437 - 445. [Abstract] [Full Text] [PDF]

				D. M. Koelle, Z. Liu, C. L. McClurkan, R. C. Cevallos, J. Vieira, N. A. Hosken, C. A. Meseda, D. C. Snow, A. Wald, and L. Corey Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor PNAS, October 28, 2003; 100(22): 12899 - 12904. [Abstract] [Full Text] [PDF]

				J. Neumann, A. M. Eis-Hubinger, and N. Koch Herpes Simplex Virus Type 1 Targets the MHC Class II Processing Pathway for Immune Evasion J. Immunol., September 15, 2003; 171(6): 3075 - 3083. [Abstract] [Full Text] [PDF]

				L. BenMohamed, G. Bertrand, C. D. McNamara, H. Gras-Masse, J. Hammer, S. L. Wechsler, and A. B. Nesburn Identification of Novel Immunodominant CD4+ Th1-Type T-Cell Peptide Epitopes from Herpes Simplex Virus Glycoprotein D That Confer Protective Immunity J. Virol., September 1, 2003; 77(17): 9463 - 9473. [Abstract] [Full Text] [PDF]

				D. M. Koelle and L. Corey Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research Clin. Microbiol. Rev., January 1, 2003; 16(1): 96 - 113. [Abstract] [Full Text] [PDF]

				Z. Mikloska and A. L. Cunningham Alpha and Gamma Interferons Inhibit Herpes Simplex Virus Type 1 Infection and Spread in Epidermal Cells after Axonal Transmission J. Virol., December 1, 2001; 75(23): 11821 - 11826. [Abstract] [Full Text]

				D. M. Koelle, H. B. Chen, M. A. Gavin, A. Wald, W. W. Kwok, and L. Corey CD8 CTL from Genital Herpes Simplex Lesions: Recognition of Viral Tegument and Immediate Early Proteins and Lysis of Infected Cutaneous Cells J. Immunol., March 15, 2001; 166(6): 4049 - 4058. [Abstract] [Full Text] [PDF]

				D. M. Koelle, S. N. Reymond, H. Chen, W. W. Kwok, C. McClurkan, T. Gyaltsong, E. W. Petersdorf, W. Rotkis, A. R. Talley, and D. A. Harrison Tegument-Specific, Virus-Reactive CD4 T Cells Localize to the Cornea in Herpes Simplex Virus Interstitial Keratitis in Humans J. Virol., December 1, 2000; 74(23): 10930 - 10938. [Abstract] [Full Text]

				J.-I. Sin, J. J. Kim, C. Pachuk, C. Satishchandran, and D. B. Weiner DNA Vaccines Encoding Interleukin-8 and RANTES Enhance Antigen-Specific Th1-Type CD4+ T-Cell-Mediated Protective Immunity against Herpes Simplex Virus Type 2 In Vivo J. Virol., December 1, 2000; 74(23): 11173 - 11180. [Abstract] [Full Text]

				D. F. Westra, G. M. G. M. Verjans, A. D. M. E. Osterhaus, A. van Kooij, G. W. Welling, A. J. Scheffer, T. H. The, and S. Welling-Wester Natural infection with herpes simplex virus type 1 (HSV-1) induces humoral and T cell responses to the HSV-1 glycoprotein H:L complex J. Gen. Virol., August 1, 2000; 81(8): 2011 - 2015. [Abstract] [Full Text]

				Z. Mikloska, M. Ruckholdt, I. Ghadiminejad, H. Dunckley, M. Denis, and A. L. Cunningham Monophosphoryl Lipid A and QS21 Increase CD8 T Lymphocyte Cytotoxicity to Herpes Simplex Virus-2 Infected Cell Proteins 4 and 27 Through IFN-{gamma} and IL-12 Production J. Immunol., May 15, 2000; 164(10): 5167 - 5176. [Abstract] [Full Text] [PDF]

				L. Bouhdoud, P. Villain, A. Merzouki, M. Arella, and C. Couture T-Cell Receptor-Mediated Anergy of a Human Immunodeficiency Virus (HIV) gp120-Specific CD4+ Cytotoxic T-Cell Clone, Induced by a Natural HIV Type 1 Variant Peptide J. Virol., March 1, 2000; 74(5): 2121 - 2130. [Abstract] [Full Text]

				J.-I. Sin, V. Ayyavoo, J. Boyer, J. Kim, R. B. Ciccarelli, and D. B. Weiner Protective immune correlates can segregate by vaccine type in a murine herpes model system Int. Immunol., November 1, 1999; 11(11): 1763 - 1773. [Abstract] [Full Text] [PDF]

				Z. Mikloska, P. P. Sanna, and A. L. Cunningham Neutralizing Antibodies Inhibit Axonal Spread of Herpes Simplex Virus Type 1 to Epidermal Cells In Vitro J. Virol., July 1, 1999; 73(7): 5934 - 5944. [Abstract] [Full Text]

				D. M. Koelle, J. M. Frank, M. L. Johnson, and W. W. Kwok Recognition of Herpes Simplex Virus Type 2 Tegument Proteins by CD4 T Cells Infiltrating Human Genital Herpes Lesions J. Virol., September 1, 1998; 72(9): 7476 - 7483. [Abstract] [Full Text] [PDF]